REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,466,343 | +41.8% | 89,102 | +37.1% | 0.01% | +60.0% |
| Q2 2023 | $1,738,937 | +24.9% | 65,007 | +1.2% | 0.01% | +25.0% |
| Q1 2023 | $1,392,002 | -5.1% | 64,266 | +4.4% | 0.00% | -20.0% |
| Q4 2022 | $1,466,240 | +21.7% | 61,555 | +0.8% | 0.01% | +25.0% |
| Q3 2022 | $1,205,000 | +22.5% | 61,091 | +21.1% | 0.00% | +33.3% |
| Q2 2022 | $984,000 | -49.8% | 50,465 | -34.3% | 0.00% | -25.0% |
| Q1 2022 | $1,959,000 | +1.3% | 76,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,933,000 | -8.5% | 76,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,113,000 | -13.3% | 76,800 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $2,438,000 | -7.6% | 76,800 | +33.6% | 0.01% | -16.7% |
| Q1 2021 | $2,638,000 | +22.7% | 57,500 | +5.9% | 0.01% | +20.0% |
| Q4 2020 | $2,150,000 | +164.1% | 54,300 | +132.1% | 0.01% | +150.0% |
| Q3 2020 | $814,000 | +10.1% | 23,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $739,000 | +54.6% | 23,400 | +7.3% | 0.00% | 0.0% |
| Q1 2020 | $478,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |